Canada markets open in 37 minutes

IM Cannabis Corp. (IMCC.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.78000.0000 (0.00%)
At close: 01:11PM EDT
Full screen
Previous Close0.7800
Open0.0000
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume17,695
Market Cap10.447M
Beta (5Y Monthly)1.90
PE Ratio (TTM)N/A
EPS (TTM)-0.7400
Earnings DateMay 13, 2024 - May 17, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.25
  • CNW Group

    IMC to transfer its Oranim Pharmacy shares back to the seller

    IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the seller.

  • PR Newswire

    IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market

    IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, entered, through its subsidiary, a strategic distribution agreement with Vessel Brand Inc, a subsidiary of Flora Growth Corp. ("Flora"), a global consumer-packaged goods leader and pharmaceutical distributor, headquartered in Carlsbad, CA.

  • CNW Group

    Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market

    IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, and Avant Brands Inc. (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BU0) ("Avant") a leading producer of innovative cannabis products, jointly announce the signing of an international trademark licensing agreement (the "Licensing Agreement") granting Adjupharm GmbH, IMC's German subsidiary ("Adjupharm" or "IMC Germany", as applicable), the exclusive